Navigation Links
Alzheimer's Drug Discovery Foundation and the Lewy Body Dementia Association Invite Scientists to Apply for LBD Grant Award Program
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and the Lewy Body Dementia Association (LBDA) invite scientists from the biotechnology industry and academia worldwide to apply for a new collaborative research grant award entitled Lewy Body Dementia Biomarker Research Award. The goal of the program is to catalyze the discovery of innovative biomarkers that aid in early diagnosis, detection and disease monitoring of Lewy body dementias.

Lewy body dementias (LBD) are the second most common form of degenerative dementia in the elderly, affecting an estimated 1.3 million people in the United States. Yet many individuals who have LBD are misdiagnosed, most commonly with Alzheimer's or Parkinson's diseases. Developing effective biomarkers is key to helping to correctly diagnose the disease, monitor disease progression and develop effective new drugs to treat, prevent and cure LBD.

The total pool of grant funds available for fiscal year 2009 is $100,000. Applications may be submitted by non-profit academic institutions and for-profit public and private biotechnology companies.

Applications are available at www.alzdiscovery.org. The submission deadline date is November 1, 2009. Applications will be reviewed by an independent Scientific Review Committee convened by ADDF and LBDA and comprised of leading experts in the neurodegenerative disease drug discovery and development research field and biotechnology investment community. Funding will be announced in spring 2010.

For more information about ADDF or to speak with Dr. Fillit, please contact Filomena Machleder at 212-901-8004 or fmachleder@alzdiscovery.org. For information about LBDA, please contact Caite Schulz at 404-935-6444 ext. 104 or cschulz@lbda.org.

About the Alzheimer's Drug Discovery Foundation (ADDF)

ADDF (www.alzdiscovery.org) is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. We award grants to leading scientists conducting breakthrough drug discovery research. ADDF uses a venture philanthropy model to bridge the worldwide funding gap between basic research and later-stage development, using any return on investment to support new research. Since 1998, we have received over 1,600 requests to fund new ideas for Alzheimer's drugs. For all, we provided expert reviews and recommendations to advance their programs. We granted more than $35M to fund over 240 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 12 countries. The ADDF website carries the latest, vetted news on Alzheimer's disease, updated weekly.

About the Lewy Body Dementia Association (LBDA)

LBDA is the only organization in the United States that provides comprehensive information, education and support for the 1.5 million people afflicted by Lewy body dementias. LBDA's Scientific Advisory Council (SAC) is comprised of leading experts in research and clinical management of Lewy body dementias from the United States, Canada, the United Kingdom and Japan. To learn more about LBDA, visit www.lbda.org


'/>"/>
SOURCE Alzheimer's Drug Discovery Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
2. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
3. PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration
4. PTC Therapeutics Announces Drug Discovery Collaboration With Roche
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Alzheimers Drug Discovery Foundation Hosts 10th International Conference on Alzheimers Drug Discovery - September 14-15
7. Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
8. Discovery of natural odors could help develop mosquito repellents
9. PharmatrophiX, Initially Funded by the Alzheimers Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan
10. Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
11. SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Crucial ... Clinical Studio Version 4.1, greatly improves performance of the platform. In particular, Version ... generate tremendous volumes of data to be collected on a per patient basis. ...
(Date:5/5/2016)... BLUE BELL, Pa. , May 5, 2016 /PRNewswire/ ... X. Powers and Lorna Weir launching ... atypical, un-agency way? Because they believe that truly helping ... dynamic world of healthcare now demands a different type ... multidisciplinary strategy lab serving the pharmaceutical, biotechnology and medical ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Proove Biosciences, ... announce a strategic partnership with McGill University . The partnership is designed to ... market in order to help patients in pain. With the new agreement, researchers at ...
(Date:5/4/2016)... ... May 04, 2016 , ... PBI-Gordon Corporation is pleased to ... , Doug began his career at PBI-Gordon in February 1988, after finishing his ... variety of roles, ranging from customer service to national product manager, to helping develop, ...
Breaking Biology Technology:
(Date:3/15/2016)... 2016 --> --> ... Market Research "Digital Door Lock Systems Market - Global Industry ... the global digital door lock systems market in terms of ... is forecast to grow at a CAGR of 31.8% during ... medium enterprises (MSMEs) across the world and high industrial activity ...
(Date:3/11/2016)... 2016 --> ... "Image Recognition Market by Technology (Pattern Recognition), by Component ... Deployment Type (On-Premises and Cloud), by Industry Vertical and ... MarketsandMarkets, the global market is expected to grow from ... by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... BEACH GARDENS, Fla. , March 9, 2016 ... identity management authentication and enrollment solutions, today announced ... DigitalPersona ® Altus multi-factor authentication ... IT and InfoSec managers to step-up security where ... Washington, DC . ...
Breaking Biology News(10 mins):